
AML in 2016: Where we are now?
Keywords: لوسمی لنفوبلاستیک حاد; Acute leukemia forum; Acute lymphoblastic leukemia; Acute myeloid leukemia; ALL; AML; Blinatumomab; Genomics; IDH; Minimal residual disease; MRD;